6533b835fe1ef96bd129f64d

RESEARCH PRODUCT

HPV vaccine hesitancy among parents of female adolescents: a pre-post interventional study

Sara PalmeriFrancesco VitaleFanny PojeroClaudio CostantinoNicolò CasuccioGianmarco VenturaAlessandra CasuccioClaudio D'angelo

subject

0301 basic medicineGynecologymedicine.medical_specialtybusiness.industry030106 microbiologyPublic Health Environmental and Occupational HealthGeneral MedicinePublic Health Human papillomavirus vaccination preventionSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineText miningFamily medicinemedicine030212 general & internal medicinebusiness

description

Human papillomavirus (HPV) is the most common sexually transmitted infection in female adolescents. The highest infection rate is found among individuals aged 15-24 years, and the HPV vaccine represents an opportunity to reduce the burden of cervical cancer caused by HPV types 16 and 18. The World Health Organization has defined girls aged 9e13 years as the priority target for HPV vaccination. In Italy, in accordance with international public health guidelines, HPV vaccination wasfree and actively offered to all girls during their 12th year of life (from the completion of 11 years until the age of 12 years) between 2007 and 2008, establishing a target vaccination coverage of 95% within 5 years of the start of the campaign.

yearjournalcountryeditionlanguage
2017-05-17
10.1016/j.puhe.2017.05.009http://hdl.handle.net/10447/265053